Protein and Performance (PROPER) in Endurance Athletes

NCT ID: NCT05426447

Last Updated: 2024-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-23

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study is a parallel group design with randomised allocation to either a 1) reduced protein diet (RP) or a 2) normal protein diet (NP). The two groups will be pair-matched based on habitual dietary protein intake, endurance training, endurance performance, and sex.

The aim of the study is to investigate the effects of reducing dietary protein (\~1g protein/kg body mass) compared to an eucaloric normal protein diet (\~2g protein/kg body mass) for 6 weeks in well-trained endurance athletes on endurance performance, body composition, skeletal muscle protein synthesis, and health-related outcomes.

The hypothesis is that endurance performance will maintain or even be improved in well-trained endurance athletes after a 6-week dietary intervention of an eucaloric, protein reduced diet compared to a normal protein rich diet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Design: The present study will include two phases: a 3-week run-in period, and a 6-week intervention of controlled diets containing either a reduced dietary protein (RP) or normal (habitual) protein (NP). The run-in period serves as a period for obtaining general activity data and habitual dietary and training habits in order to match the groups before entering the dietary intervention period.

Subjects and dietary goals: The study is aiming at including 20 male endurance athletes exercising \~15hrs+/week. The 20 males will be pair-matched based on habitual endurance training, habitual dietary protein intake, and endurance performance, and allocated in a randomised order to: 1) a reduced-protein diet (RP) or 2) a normal-protein diet (NP).

3-weeks run-in period: After a minimum of 7 days after written consent has been obtained, the run-in period will begin. Habitual endurance training volumes will be registered in an online platform (TrainingPeaks) and daily activity level will be monitored using an accelerometer (SENS) throughout the run-in and diet intervention period. "Heavy water" (D2O) will be ingested in a large bolus (3.5ml/kg LBM) upon beginning of the run-in period and plasma enrichments will be maintained throughout the study period by ingesting small daily boluses. This serves to determine skeletal muscle protein synthesis throughout the study.

6-weeks dietary intervention: The diets will be eucaloric and the estimated energy percentages for macronutrients will be as follows: RP - Protein \~7E%, Carbohydrate \~63E%, Fat \~29E%. NP - Protein \~16E%, Carbohydrate \~53E%, Fat \~30E%. Weekly urine and faeces samples will be collected during the run-in period and dietary intervention and the controlled diets will be supplied weekly for the participants.

Testing: Extensive endurance performance and metabolic testing will be performed prior to-, and during the intervention on weeks -1, 0 (Pre), 3 (Mid), and 6 (Post). The tests include: Body composition by DXA-scanning, resting metabolic rate by online respirometry using a Vyntus (Jaeger, PCX), venous blood-, and skeletal muscle biopsy sampling from m. Vastus Lateralis, a standardised breakfasts, endurance cycling on an electro-magnetically braked bike (Lode Excalibur) or running on a motorised treadmill (Woodway), and haemoglobin mass measuring using a modified version of the CO-rebreathing method.

The body mass will be kept unchanged during the 6-weeks dietary intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diet, Healthy Protein Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A pair-matched group, parallel design within each sex
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Reduced protein diet

A 6-week eucaloric dietary intervention of reduced protein intake (\~1g protein/kg body mass). The diet will, hence, contain \~7E% protein, \~63E% carbohydrate, and \~29E% fat.

Participants are free-living and receive all food pre-packed from the study kitchen. The energy provision will be set to match energy balance.

Group Type EXPERIMENTAL

Dietary intervention of reduced protein intake

Intervention Type OTHER

6-wk dietary intervention of reduced protein intake

Normal protein diet

A 6-week eucaloric dietary intervention of normal protein intake (\~2g protein/kg body mass). The diet will, hence, contain \~16E% protein, \~53E% carbohydrate, and \~30E% fat.

Participants are free-living and receive all food pre-packed from the study kitchen. The energy provision will be set to match energy balance.

Group Type ACTIVE_COMPARATOR

Dietary intervention of normal protein intake

Intervention Type OTHER

6-wk dietary intervention of normal protein intake

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary intervention of reduced protein intake

6-wk dietary intervention of reduced protein intake

Intervention Type OTHER

Dietary intervention of normal protein intake

6-wk dietary intervention of normal protein intake

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Endurance athlete
* Exercising at least 10hrs per week
* Habitual dietary protein intake \~2g/kg body mass
* BMI\<25

Exclusion Criteria

* Food allergies that exclude the controlled diet
* Inconsistent endurance training load
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University Medical Center

OTHER

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bente Kiens

Professor of Exercise, Nutrition and Metabolism, D Sci, PhD, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicki W Almquist, Post Doc

Role: STUDY_DIRECTOR

University of Copenhagen

Bente Kiens, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Copenhagen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Copenhagen

Copenhagen, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PROPER

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Protein Requirements in Endurance-trained Athlete
NCT02478801 COMPLETED EARLY_PHASE1
Resistance Exercise in Healthy Men
NCT01220037 COMPLETED NA